NCT05092568 (COVID-19) is a clinical trial in Coronavirus Disease 2019, sponsored by Saglik Bilimleri Universitesi.

Who is sponsoring NCT05092568?

NCT05092568 is sponsored by Saglik Bilimleri Universitesi.

What condition does NCT05092568 study?

NCT05092568 studies Coronavirus Disease 2019, Vaccinia, Symptoms and Signs.

Is NCT05092568 still recruiting?

NCT05092568 is currently status unknown. Last updated 6 May 2022.

Last reviewed 2022-05-06 · How we verify

NCT05092568: COVID-19

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Status unknown Last updated 6 May 2022

What this trial tests

trial in Coronavirus Disease 2019 in 45 participants. Status unknown.

Timeline

5 May 2022

Primary endpoint
15 July 2022

15 July 2022

Quick facts

Lead sponsor	Saglik Bilimleri Universitesi
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	5 May 2022
Primary completion	15 July 2022
Estimated completion	15 July 2022
Sites	1 location across Turkey (Türkiye)

Conditions studied

Coronavirus Disease 2019 — all drugs for Coronavirus Disease 2019 →
Vaccinia — all drugs for Vaccinia →
Symptoms and Signs — all drugs for Symptoms and Signs →

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Eligibility, female only, with Coronavirus Disease 2019 or Vaccinia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

comparison of general characteristics of patients diagnosed COVID-19 positive followed In service

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronavirus Disease 2019

Currently open trials in the same condition.

NCT05160636 — A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza · active not recruiting
NCT05164744 — Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors · recruiting

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

NCT07499986 — Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery · NA · not yet recruiting
NCT07516340 — Gamification-Based Peer Education in Nursing Students: Effects on Sexual Health Literacy and Attitudes · NA · not yet recruiting
NCT07520435 — Short-Term Mindfulness Intervention for Anxiety and Maternal Attachment in NICU Mothers · NA · not yet recruiting
NCT07528001 — Hypno-Breastfeeding Education and Postpartum Outcomes · NA · not yet recruiting
NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05092568 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saglik Bilimleri Universitesi
Last refreshed: 6 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05092568.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing